Home > Riviste > Acta Phlebologica > Fascicoli precedenti > Acta Phlebologica 2020 December;21(3) > Acta Phlebologica 2020 December;21(3):56-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

CASE REPORT   Freefree

Acta Phlebologica 2020 December;21(3):56-9

DOI: 10.23736/S1593-232X.20.00482-8

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Foot acrosyndromes in patients with COVID-19: the podiatrist’s approach

Innocenzo S. SECOLO 1 , Rosario E. TOSCANO 2, Daniela RISSO 3, Giuseppe SECOLO 4

1 University of Palermo, Palermo, Italy; 2 Toscano Clinic of Podiatry, Catania, Italy; 3 Unit of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy; 4 Unit of Biotypology, University of Palermo, Palermo, Italy



Acrocyanosis is a permanent dystonic vascular acrosyndrome. Vascular acrosyndromes often occur with changes in temperature and skin color. They can also be associated with paresthesia or hypoesthesia as well as ischemic damage and necrosis in the worst cases. Often the acrosyndromes can also be the manifestation of other pathologies, as is the case of viral infections, where they could favor early diagnosis. On March 29, 2020, five weeks after the first Italian case of COVID-19, the first report of acro-ischemic lesions appeared in asymptomatic positive children, the confirmation of which was common throughout Italy with the report of some dozens of cases and still new cases are reported every day. From these data, acrosyndromes manifestations occurs in healthy children and adolescents; often mistaken for chilblains or allergic dermatitis for erythematous patches. Three recent studies conducted in Wuhan show that hypertension is often associated with people with COVID-19 and increases the risk of pathological complications. The new coronavirus responsible for acute and severe respiratory syndrome (SARS-CoV-2) binds to target cells through the angiotensin 2 converting enzyme, which is expressed on the epithelial cells of the lungs, intestine, kidney and blood vessels. Our hypothesis is that the podiatrist, in his clinical practice, could consider the possible dermoscopic differences in the vascular aspect of the nail capillaries and their association with the clinical state of the disease. Education, prevention, compliance are the keywords of the operator/user relationship within the podiatry study.


KEY WORDS: Podiatry; Foot; COVID-19; Education

inizio pagina